REGEN BIOPHARMA, INC. Interest Payable, Current
REGEN BIOPHARMA, INC. (RGBP) had Interest Payable, Current of $517.75 thousand as of 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:InterestPayableCurrent · last filed 2026-08-17
- 2026-06-30: Interest Payable, Current $517.75K.
- 2025-09-30: Interest Payable, Current $476.43K.
- 2024-09-30: Interest Payable, Current $362.53K.
| Period end | Interest Payable, Current |
|---|---|
| 2026-06-30 | $517.75K 10-Q · filed 2026-08-17 |
| 2025-09-30 | $476.43K 10-Q · filed 2026-08-17 |
| 2024-09-30 | $362.53K 8-K · filed 2024-11-29 |